A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors

Area of Science:

• Genetics
• Molecular Biology
• Gene Therapy

Background:

• Human artificial chromosomes (HACs) are crucial for gene transfer and expression studies.
• Existing HAC delivery methods have limitations in efficiency and capacity.
• Viral vectors offer potential for improved gene delivery systems.

Purpose of the Study:

• To develop a highly efficient method for delivering gene-expressing HACs into human cells using herpes simplex virus type 1 (HSV-1) amplicon vectors.
• To establish functional HACs for gene complementation studies.
• To investigate cell-type-specific HAC stability.

Main Methods:

• Utilized infectious HSV-1 amplicon vectors for HAC delivery.
• Established gene-expressing HACs in glioma, kidney, and lung-derived human cells.
• Developed and tested an HSV-1 HPRT HAC vector for genetic deficiency complementation.
• Compared transduction efficiency with lipofection-mediated delivery.
• Analyzed HAC stability across different cell types.

Main Results:

• Achieved highly efficient gene-expressing HAC establishment in multiple human cell types.
• Demonstrated functional complementation of genetic deficiency using an HPRT-expressing HAC.
• HSV-1 HAC amplicon transduction efficiency was orders of magnitude higher than lipofection.
• Identified significant differences in HAC stability between cell types.

Conclusions:

• HSV-1 amplicon vectors represent a significant advance in HAC technology for efficient gene transfer and expression in human cells.
• This method enables the development of high-capacity viral vector systems for HAC-based gene therapy.
• Understanding cell-type-specific HAC instability is critical for optimizing HAC development and gene expression strategies.